Table 4.
Frequency of Detection of −/−K111 in DNA from African and African American patients with different diseases
| Disease | Origin | No. Tested | −/−K111 | Frequency of −/−K111 (%) | X 2 | P value |
|---|---|---|---|---|---|---|
| African | ||||||
| Healthy | Nigeria | 127 | 3 | 2.36 | ||
| 14.583 | 0.00001# | |||||
| African Breast Cancer | Nigeria | 139 | 2 | 1.44 | 0.307 | ns |
| 18.2223 | 0.00002# | |||||
| Total African | 266 | 5 | 1.8 | 0.00001# | ||
| HIV/AIDS | Michigan, New York | 6 | 1 | 16.6 | 0.216 | ns |
| unclassified | Michigan, New York | 5 | 0 | 0 | 0.564 | ns |
| HIV LTNP | Baltimore | 18 | 1 | 5.6 | 0.340 | ns |
| DLBCL | Michigan | 3 | 1 | 33 | 1.41 | ns |
| CTCL | Michigan | 4 | 0 | 0 | 0.452 | ns |
| Breast Cancer | Michigan | 3 | 0 | 0 | 0.574 | ns |
| Total African American all diseases | 39 | 3 | 7.6 | 1.821 | ns | |
Statistical analysis was determined between healthy individuals and patients of the same ethnicity. # indicates significant differences between healthy Caucasian individuals and healthy African individuals or African patients with breast cancer